Biologic and antigenic characteristics of epstein-barr virus-related herpesviruses of chimpanzees and baboons
- 15 September 1977
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 20 (3) , 448-459
- https://doi.org/10.1002/ijc.2910200318
Abstract
Leukocyte-transforming agents were isolated in baboon leukocytes inoculated with oral excretions from immunosuppressed chimpanzees. The transformed lymphoblasts had B cell surface markers and harbored herpes-type virus particles; 5-10% of the cells contained cytoplasmic antigens reactive with Epstein-Barr virus (EBV)-antibody-positive chimpanzee, human and baboon sera. These sera also neutralized the transforming activity of the chimpanzee virus. Long-term lymphoid cell lines were established from circulating lymphocytes of normal baboons: two from Papio cynocephalus and three from P. hamadryas. The cells had B cell surface markers, contained herpes-type virus particles and produced virus with leukocyte-transforming activity. No virus-associated nuclear antigen was detectable with reference baboon and chimpanzee sera; however, the cells reacted with selected human sera containing antibodies to EBV nuclear antigen (EBNA). Absorption experiments confirmed the specificity of this reaction. Baboon lymphoblasts produced baboon virus-associated soluble complement-fixing (CF/S) antigen. Baboon sera had CF antibodies to viral (CF/V) antigen derived from EBV but failed to react with EBV-associated CF/S antigen. Chimpanzee and baboon herpesviruses had similar in vitro host cell ranges but were different from those of EBV. Inoculation of baboons, rhesus monkeys and cottontop marmosets failed to produce detectable illness or palpable tumors.Funding Information
- Virus Cancer Program (1-CP-33333)
This publication has 27 references indexed in Scilit:
- Typical Type-C Virus in Human Leukemia 2JNCI Journal of the National Cancer Institute, 1976
- Complement-fixing Antibodies Reactive with Epstein-Barr Virus in Sera of Marmosets and ProsimiansExperimental Biology and Medicine, 1974
- Epstein-Barr Virus-Associated Antigens Activated in Human Cells by 5-BromodeoxyuridineExperimental Biology and Medicine, 1972
- ORAL EXCRETION OF EPSTEIN-BARR VIRUS BY HEALTHY SUBJECTS AND PATIENTS WITH INFECTIOUS MONONUCLEOSISThe Lancet, 1972
- A POPULATION OF LYMPHOCYTES BEARING A MEMBRANE RECEPTOR FOR ANTIGEN-ANTIBODY-COMPLEMENT COMPLEXESThe Journal of Experimental Medicine, 1970
- Epstein-Barr Virus-Induced Viral and Soluble Complement-Fixing Antigens in Burkitt Lymphoma Cell CulturesExperimental Biology and Medicine, 1970
- The Incidence of Complement-Fixing Antibodies to Herpes Simplex and Herpes-Like Viruses in Man and Rhesus MonkeysExperimental Biology and Medicine, 1968
- Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells.Proceedings of the National Academy of Sciences, 1967
- Immunofluorescence in Cells Derived from Burkitt's LymphomaJournal of Bacteriology, 1966
- MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Journal of Experimental Medicine, 1965